Posts Tagged ‘Biotech Stocks’

WSB has banner day, HGSI boosts volume, SOLR sets

Wednesday, November 17th, 2010

WSB Holdings Inc. (NasdaqGM: WSB) gained 19.06 percent in price Wednesday to close at $2.77. Volume of 9,977 shares more than tripled its daily average. Headquartered in the Baltimore-Washington corridor, WSB serves the banking needs of growing businesses with commercial lending facilities, commercial real estate financing, residential mortgages, and residential construction financing for both developers and individual home owners.

Human Genome Sciences Inc. (NasdaqGM: HGSI) was active in Wednesday trading, with volume of 32,900,723, more than 10 times its usual daily volume. HGSI shares faded, however, 5.29 percent in price to $24.51. Tuesday, HGSI and GlaxoSmithKline PLC (GSK) announced that the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) has voted 13 to 2 to recommend that the FDA approve BENLYSTA® (belimumab) for the treatment of autoantibody-positive patients with active systemic lupus erythematosus (SLE).

GT Solar International Inc. (NasdaqGS: SOLR) fell in price Wednesday by 15.38 percent to close at $7.10. Its volume of 10,123,799 shares towered over its three-month daily average of 3,485,580. SOLR is a global provider of polysilicon production technology, and sapphire and silicon crystalline growth systems and materials for the solar, LED and other specialty markets

CMED leaps, RF sells, CBMX capsizes

Wednesday, November 17th, 2010

China Medical Technologies Inc. (NasdaqGS: CMED) saw its price improve 18.52 percent Wednesday to $13.95. Today’s volume was 1,775,545 shares, which trumps its daily average of 235,312. The Beijing-based CMED reported revenues of RMB201.8 million (US$30.2 million) for 2Q FY2010, representing a 21.5% increase from the corresponding period of FY2009. Net loss was RMB2.9 million (US$0.4 million) for 2Q FY2010, representing a 94.1% decrease from the corresponding period of FY2009.

Regions Financial Corp. (NYSE: RF) had an active Wednesday, trading in 49,964,333 shares, nearly triple its three-month daily average. RF shares sank 8.11 percent in price to $5.44. RF serves customers in 16 states across the South, Midwest and Texas, and through its subsidiary, Regions Bank, operates approximately 1,800 banking offices and 2,200 ATMs.

CombiMatrix Corporation (NasdaqGM: CBMX) fell in price Wednesday afternoon by 15.65 percent to $2.21. Volume was a scant 27,295 shares, still more than double its three-month daily average. The Irvine, Calif.-based molecular diagnostics company reported last week that revenues for the third quarter of 2010 increased 68 percent to $1.0 million from $603,000 in Q3 2009.

ISLN spikes, QQQQ among volume leaders, ASTM ailing

Monday, November 15th, 2010

Isilon Systems Inc. (NasdaqGM: ISLN) enjoyed a profitable day Monday, jumping 28.45 percent in price to close at $33.77. Volume in ISLN was 35,703,591 shares, compared to a daily average of just over one million. On Monday, EMC Corp. said it has signed a $2.25 billion deal to acquire Isilon Systems Inc. in yet another step in the consolidation of the increasingly important data-storage industry.

PowerShares QQQ (NasdaqGM: QQQQ) traded widely Monday in 56,163,936 shares. The figure was still below its three-month daily average of 73,899,700. The stock suffered in price, though, 0.37 percent to $52.31.

Aastrom Biosciences Inc. (NasdaqCM: ASTM) fell in price Monday’s trading by 15.48 percent to $3.55. Volume in ASTM was 4,168,049, or about four times its normal daily average. The Ann Arbor, Mich.-based company is a leading developer of expanded autologous cellular therapies for the treatment of severe cardiovascular diseases.

SPPH, MRES, IROG surge

Thursday, November 11th, 2010

Spencer Pharmaceutical Inc. (Pink Sheets: SPPH) surged 53.32 percent in price by noon ET Thursday to 42.9 cents. Volume was 4.35 million shares. The Boston-based company announced Thursday that an unsolicited offer received on November 4, 2010 is at a premium of $0.97 per share, making the potential transaction valued at $245 million. SPPH has opted to continue to keep the purchaser’s name confidential until such time as a timeline can be presented and the approval of the board of directors can be obtained.

NeuroBiotech Corp. (Pink Sheets: MRES) surged 40.91 percent by midday Thursday to a price of 3.1 cents, based on volume of 1,611,044 million shares. The company, based out of Basel, Switzerland, is currently actively working towards the commercialization of natural products called “Neuroceuticals®”, specially designed to restore the nervous system equilibrium and improve the state of health as well as the quality of life of people affected by stress-related disorders.

Ironwood Gold Corp. (OTCBB: IROG) picked up 3.45 percent in price by noon ET Thursday to 12 cents. Volume in the stock traded at 834, 580 shares. Wednesday, the Scottsdale, Ariz.-based junior miner announced favorable results of the Mobile Metal Ion (MMI) soil survey that was completed October 12 at its Rock Creek property in Nevada.

PEGA powers up, MGM hot ticket, CERS falls

Wednesday, November 10th, 2010

Pegasystems Inc. (NasdaqGS: PEGA) climbed in price 19.21 percent Wednesday to close at $31.46.  PEGA enjoyed volume of 2,430,406 shares, six times its normal daily volume. The Cambridge, Mass-based CRM solutions company announced Tuesday its 13th consecutive quarter of record revenue, with the figure climbing 39 percent to $90 Million over the same quarter last year, although net income was down 48 percent to $3.1 Million.

MGM Resorts International Inc. (NYSE: MGM) more than doubled its average daily volume Wednesday, trading in 59,589,549 shares. The resort company’s stock moved ahead 2.88 percent in price to close at $13.38, despite word Wednesday that Atlantic City’s casino gambling revenue fell 12 percent in October, after Pennsylvania and West Virginia added table games and new casinos opened in Philadelphia and Maryland.

Cerus Corporation (NasdaqGM: CERS) had a tough time Wednesday, falling in price 20.89 percent to close trading at $2.50. Volume in CERS shares was 3,905,110, or more than 12 times its normal volume. The dire news came after the Concord, Calif.-based biotechnology company announced a public offering of approximately 7.4 million units. The company is issuing both stock and warrants to buy stock. Each unit consists of one share of common stock and a warrant to buy 0.5 share of common stock. Each warrant will have an exercise price of $3.20 per share and will be exercisable six months after they are issued.